Page last updated: 2024-09-04

ezetimibe and Eccentro-Osteochondrodysplasia

ezetimibe has been researched along with Eccentro-Osteochondrodysplasia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alméciga-Diaz, CJ; Garzón, R; Gorshkov, K; Guzman, E; Hidalgo, OA; Li, R; Olarte-Avellaneda, S; Pimentel-Vera, LN; Puentes-Tellez, MA; Rodríguez-López, A; Rojas-Rodriguez, AF; Zheng, W1

Other Studies

1 other study(ies) available for ezetimibe and Eccentro-Osteochondrodysplasia

ArticleYear
Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA.
    Journal of medicinal chemistry, 2019, 07-11, Volume: 62, Issue:13

    Topics: Catalytic Domain; Chondroitinsulfatases; Chromones; Enzyme Inhibitors; Ezetimibe; Fibroblasts; HEK293 Cells; Humans; Lysosomes; Microtubule-Associated Proteins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mucopolysaccharidosis IV; Pichia; Protein Binding; Protein Stability; Rare Diseases; Recombinant Proteins; RNA-Binding Proteins

2019